Metastatic thyroid cancer occurring as an unknown primary lesion: The role of F-18 FDG positron emission tomography

Faut Dede; Nyimas Diana Yulisa Ajoedi; Selim M. Ansari; Suman Jana; Sherif I. Heiba; Hussein M. Abdel-Dayem

doi:10.1097/00003072-200105000-00004

Metastatic thyroid cancer occurring as an unknown primary lesion: The role of F-18 FDG positron emission tomography

Faut Dede
, Nyimas Diana Yulisa Ajoedi
, Selim M. Ansari
, Suman Jana
, Sherif I. Heiba
, Hussein M. Abdel-Dayem

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.

Original language	English
Pages (from-to)	396-399
Number of pages	4
Journal	Clinical Nuclear Medicine
Volume	26
Issue number	5
DOIs	https://doi.org/10.1097/00003072-200105000-00004
State	Published - 2001
Externally published	Yes

Keywords

F-18 Fluorodeoxyglucose Positron Emission Tomography
Metastatic Thyroid Cancer
Unknown Primary

Access to Document

10.1097/00003072-200105000-00004

Cite this

@article{5408f17092f348c494152d261a2ebbbf,

title = "Metastatic thyroid cancer occurring as an unknown primary lesion: The role of F-18 FDG positron emission tomography",

abstract = "Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.",

keywords = "F-18 Fluorodeoxyglucose Positron Emission Tomography, Metastatic Thyroid Cancer, Unknown Primary",

author = "Faut Dede and \{Yulisa Ajoedi\}, \{Nyimas Diana\} and Ansari, \{Selim M.\} and Suman Jana and Heiba, \{Sherif I.\} and Abdel-Dayem, \{Hussein M.\}",

year = "2001",

doi = "10.1097/00003072-200105000-00004",

language = "English",

volume = "26",

pages = "396--399",

journal = "Clinical Nuclear Medicine",

issn = "0363-9762",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

TY - JOUR

T1 - Metastatic thyroid cancer occurring as an unknown primary lesion

T2 - The role of F-18 FDG positron emission tomography

AU - Dede, Faut

AU - Yulisa Ajoedi, Nyimas Diana

AU - Ansari, Selim M.

AU - Jana, Suman

AU - Heiba, Sherif I.

AU - Abdel-Dayem, Hussein M.

PY - 2001

Y1 - 2001

N2 - Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.

AB - Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients. The authors describe two patients who had metastatic disease from an unknown primary lesion. F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland. The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.

KW - F-18 Fluorodeoxyglucose Positron Emission Tomography

KW - Metastatic Thyroid Cancer

KW - Unknown Primary

UR - https://www.scopus.com/pages/publications/0035034347

U2 - 10.1097/00003072-200105000-00004

DO - 10.1097/00003072-200105000-00004

M3 - Article

C2 - 11317017

AN - SCOPUS:0035034347

SN - 0363-9762

VL - 26

SP - 396

EP - 399

JO - Clinical Nuclear Medicine

JF - Clinical Nuclear Medicine

IS - 5

ER -

Metastatic thyroid cancer occurring as an unknown primary lesion: The role of F-18 FDG positron emission tomography

Abstract

Keywords

Access to Document

Fingerprint

Cite this